Alterity Therapeutics to Current on the Life Sciences Investor Discussion board

Fenika Bench

Digital Investor Conferences MELBOURNE, Australia and SAN FRANCISCO, June 20, 2022 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Firm”), a biotechnology firm devoted to growing illness modifying therapies for neurodegenerative ailments, immediately introduced that David Stamler, M.D., Chief Government Officer will current on the […]